Condition: Von Willebrand Diseases · Glanzmann Thrombasthenia · Sponsor: University Hospital, Lille
In Willebrand disease, there is currently no test available to identify non-invasively patients with a high risk of bleeding from angiodysplasias The study propose to use a sublingual capillary bed analysis by video-microscopy, a sensitive, reproducible and non-invasive technique, to assess whether sublingual capillary density is predictive of hemorrhagic risk for patients with von Willebrand disease.
This description comes directly from the study's public registry record.
Antoine Rauch, MD,PhD · 3 20445962 (poste 29673) · antoine.rauch@chru-lille.fr
Always discuss trial participation with your own doctor first.
| CHU de Lille | Lille, Nord, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04119908